Baker Brothers Advisors - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$119,792,559
+8.3%
2,368,3780.0%0.69%
+7.8%
Q2 2023$110,579,569
+22.0%
2,368,3780.0%0.64%
+29.8%
Q1 2023$90,614,142
-30.2%
2,368,3780.0%0.49%
-36.7%
Q4 2022$129,787,114
+60.9%
2,368,3780.0%0.78%
+47.5%
Q3 2022$80,643,000
+7106.7%
2,368,378
+1900.7%
0.53%
+8700.0%
Q2 2022$1,119,000
-33.4%
118,3780.0%0.01%
-40.0%
Q1 2022$1,680,000
-32.9%
118,3780.0%0.01%
-16.7%
Q4 2021$2,504,000
-5.4%
118,3780.0%0.01%0.0%
Q3 2021$2,646,000
-9.9%
118,3780.0%0.01%
-7.7%
Q2 2021$2,937,000
-14.5%
118,3780.0%0.01%
-13.3%
Q1 2021$3,434,000
+12.4%
118,3780.0%0.02%
+25.0%
Q4 2020$3,054,000
-24.7%
118,378
-10.2%
0.01%
-25.0%
Q3 2020$4,058,000131,7880.02%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
University of Wisconsin Foundation 103,816$5,251,0136.02%
Boxer Capital, LLC 1,676,733$84,809,1554.52%
Redmile Group, LLC 1,769,684$89,510,6174.26%
Ghost Tree Capital, LLC 250,000$12,645,0004.16%
Logos Global Management LP 600,000$30,348,0004.05%
COMMODORE CAPITAL LP 565,000$28,577,7003.34%
Yiheng Capital Management, L.P. 1,221,674$61,792,2713.15%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$10,116,0003.07%
Atlas Venture Life Science Advisors, LLC 359,251$18,170,9152.81%
Perceptive Advisors 1,619,425$81,910,5172.73%
View complete list of AKERO THERAPEUTICS INC shareholders